Sinocare Inc. (SHE: 300298)

Market Cap	14.25B
Revenue (ttm)	4.21B
Net Income (ttm)	221.71M
Shares Out	553.84M
EPS (ttm)	0.40
PE Ratio	64.39
Forward PE	39.08
Dividend	0.20 (0.76%)
Ex-Dividend Date	Jun 17, 2024

Volume	3,512,556
Open	27.30
Previous Close	26.29
Day's Range	25.71 - 27.30
52-Week Range	19.19 - 35.46
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Sinocare

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers SARS-CoV-2 antibody test strips; blood glucose monitors; bi-functional blood glucose monitors; point of care testing products; digital management tool solutions; non-invasive screening products; diabetes peripheral products; and PTS and Trividia Products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It als...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 4,531
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300298

Financial Performance

In 2023, Sinocare's revenue was 4.06 billion, an increase of 2.69% compared to the previous year's 3.95 billion. Earnings were 284.40 million, a decrease of -36.31%.